Duleba Karolina, Smukalska Ewa, Pawłowska Małgorzata
Klinika Chorób Zakaźnych i Hepatologii Wieku Rozwojowego Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika.
Przegl Epidemiol. 2012;66(1):67-71.
Clostridium difficile (CD) is one of the main factors of nosocomial infections both in children and adults and the number these infections is still growing. There is an increasing number of community-associated CDAD and CDIs with no exposure to antibiotics. Tests for CD among children are not routinely conducted because of high rate of carrying (from 13 to 70% infants). The objective of a study was to assess the frequency CDI among children with diarrhea, analysis of the risk factors of CDI and to compare the course of infection and the response to the treatment depending on type of bacteria toxigenic profile.
The retrospective analysis of the clinical case record was made on 16 children at the age of 9 months to 10 years with CDI. PCR tests (Xpert C.Difficile) were used to identify CD in stool specimens.
1,6% children with diarrhea was diagnosed with CDI. It constituted 8,9 cases per 1000 admissions. All children with CDI received antibiotics before. Correlation between hospitalization and development of CDI was found in 56% children. In 62% children the toxin B-producing B strains were revealed whereas in the others hiperwirulent strains NAP1/B1/027 (38%). SIRS was found in 50% cases infected by NAP 1/B1/027.
CD may be very important etiological factor of antibiotic-associated diarrhea in hospitalized children, especially with severe diseases and community-acquired CDs. CDI should be considered in all cases of prolonged or relapse of diarrhea.
艰难梭菌(CD)是儿童和成人医院感染的主要因素之一,且这些感染的数量仍在增加。社区获得性艰难梭菌相关性腹泻(CDAD)和艰难梭菌感染(CDI)且无抗生素暴露史的病例越来越多。由于携带率高(13%至70%的婴儿),儿童中未常规进行CD检测。一项研究的目的是评估腹泻儿童中CDI的发生率,分析CDI的危险因素,并根据细菌产毒型别比较感染过程和治疗反应。
对16例年龄在9个月至10岁的CDI患儿的临床病例记录进行回顾性分析。采用PCR检测(Xpert C.Difficile)鉴定粪便标本中的CD。
1.6%的腹泻儿童被诊断为CDI。每1000例入院病例中CDI有8.9例。所有CDI患儿之前均接受过抗生素治疗。56%的患儿发现住院与CDI发生之间存在相关性。62%的患儿检测出产生毒素B的B型菌株,而其他患儿为高毒力菌株NAP1/B1/027(38%)。50%感染NAP 1/B1/027的病例出现全身炎症反应综合征(SIRS)。
CD可能是住院儿童抗生素相关性腹泻的非常重要的病因,尤其是患有严重疾病和社区获得性CD的儿童。所有腹泻持续或复发的病例均应考虑CDI。